Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Back to Agenda

Session 23: EU Landscape (continued)

Session Chair(s)

William Gregory, PhD

Senior Director, Safety and Risk Management

Pfizer Inc, United States

This session will continue discussion of the post-marketing setting in the EEA, with additional details on quality-assured pharmacovigilance systems, e.g., the Pharmacovigilance System Master File (PSMF), the role of the EU Qualified Person for Pharmacovigilance (QPPV), and EMA’s Medical Literature Monitoring (MLM) service.

Have an account?

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Session 23: EU Landscape (continued)

Session Chair(s)

William Gregory, PhD

Be informed and stay engaged.